Thryv Therapeutics to Participate at the 2024 Jefferies Global Healthcare Conference

Press Releases
Written By Thryv Therapeutics

Montreal, Quebec – May 24, 2024 – Thryv Therapeutics is pleased to announce that it will be hosting investor meetings at the Jefferies Global Healthcare Conference on Tuesday, June 4, 2024, at the Hyatt Grand Central New York. This year’s gathering will bring together 3,000 leading executives to address near-and long-term investment opportunities as well as current trends driving healthcare in the U.S. and internationally.

To schedule a meeting with Thryv Therapeutics throughout the day, please contact admin@thryvtrx.com.

About Thryv Therapeutics Inc.

Thryv Therapeutics Inc. is a privately owned company based in Montreal, Quebec, Canada. Thryv Therapeutics is pioneering a precision medicine approach to treat indications including Congenital Long QT Syndromes (LQTS), atrial fibrillation and heart failure, with potent and selective inhibitors of Serum Glucocorticoid inducible Kinase (SGK1). For more information, please visit www.thryvtrx.com.

Media Inquiries

brittany@thryvtrx.com | 514 973 0915

Thryv Therapeutics
Previous

Thryv Therapeutics to Participate in Fireside Chat During 2024 RBC Capital Markets Biotechnology Private Company Virtual Conference 
Next

Thryv Therapeutics to Present Preclinical Data of SGK1 Inhibition in Models of Drug-Induced QT Prolongation at the 2024 Heart Rhythm Society Meeting